Evidence map›Paper›PMID 42218150›Full record

ArticleNature communications2026

Pan-cancer single-cell atlases of mouse and human tumor-associated dendritic cells.

Aarushi A Caro, Daliya Kancheva, Eva Hadadi, Bram Boeckx, Clint De Nolf, Pauline M R Bardet, Kevin Verstaen, Luqing Li, Lobna Oueslati, Nil Figueras-Duch and 10 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Aarushi A Caro *Lab of Dendritic Cell Biology and Cancer Immunotherapy, VIB Center for Inflammation Research, Brussels, Belgium.
Daliya Kancheva *Lab of Dendritic Cell Biology and Cancer Immunotherapy, VIB Center for Inflammation Research, Brussels, Belgium.ORCID http://orcid.org/0000-0001-6222-0461
Eva HadadiLab of Dendritic Cell Biology and Cancer Immunotherapy, VIB Center for Inflammation Research, Brussels, Belgium.
Bram BoeckxLaboratory for Translational Genetics, Department of Human Genetics, KU Leuven, Leuven, Belgium.ORCID http://orcid.org/0000-0002-0296-6680
Clint De NolfLaboratory for ER Stress and Inflammation, VIB Center for Inflammation Research, Ghent, Belgium.ORCID http://orcid.org/0000-0002-2033-1830
Pauline M R BardetLab of Dendritic Cell Biology and Cancer Immunotherapy, VIB Center for Inflammation Research, Brussels, Belgium.ORCID http://orcid.org/0000-0003-4454-9823
Kevin VerstaenDepartment of Biomedical Molecular Biology, Ghent University, Ghent, Belgium.ORCID http://orcid.org/0000-0003-3582-0298
Luqing LiSwiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, Swiss Federal Institute of Technology in Lausanne (EPFL), Lausanne, Switzerland.
Lobna OueslatiLaboratory of Cancer Signaling, GIGA-Institute, University of Liège, Liège, Belgium.
Nil Figueras-DuchLaboratory of Cancer Signaling, GIGA-Institute, University of Liège, Liège, Belgium.
Yvon ElkrimLab of Cellular and Molecular Immunology, Brussels Center for Immunology, Vrije Universiteit Brussel, Brussels, Belgium.
Niels VandammeDepartment of Biomedical Molecular Biology, Ghent University, Ghent, Belgium.
Sofie DeschoemaekerLab of Dendritic Cell Biology and Cancer Immunotherapy, VIB Center for Inflammation Research, Brussels, Belgium.ORCID http://orcid.org/0000-0001-5449-282X
Arnaud BlommeLaboratory of Cancer Signaling, GIGA-Institute, University of Liège, Liège, Belgium.ORCID http://orcid.org/0000-0003-4183-8726
Pierre CloseLaboratory of Cancer Signaling, GIGA-Institute, University of Liège, Liège, Belgium.ORCID http://orcid.org/0000-0002-8844-9616
Sophie JanssensLaboratory for ER Stress and Inflammation, VIB Center for Inflammation Research, Ghent, Belgium.ORCID http://orcid.org/0000-0003-1702-1636
Michele De PalmaSwiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, Swiss Federal Institute of Technology in Lausanne (EPFL), Lausanne, Switzerland.ORCID http://orcid.org/0000-0001-9128-5459
Diether LambrechtsLaboratory for Translational Genetics, Department of Human Genetics, KU Leuven, Leuven, Belgium.ORCID http://orcid.org/0000-0002-3429-302X
An CoosemansLab of Tumor Immunology and Immunotherapy, Department of Oncology, Leuven Cancer Institute, KU Leuven, Leuven, Belgium.ORCID http://orcid.org/0000-0002-7321-4339
Damya LaouiLab of Dendritic Cell Biology and Cancer Immunotherapy, VIB Center for Inflammation Research, Brussels, Belgium. dlaoui@vub.be.ORCID http://orcid.org/0000-0002-3373-1403

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dendritic cells (DCs) are critical inducers of anti-tumor immunity. To achieve a comprehensive mapping of mouse and human DC subsets and states in a cancer context, here we generate pan-cancer mouse and human tumor-associated DC (TADC) scRNA-seq atlases, encompassing 14 mouse tumor models and 10 human cancer types, within which we identify several lineage-defined DC subsets along with maturation/functional states. We show that TADCs acquire an inflammatory profile with tumor progression and that tumor-mediated reprogramming occurs within the DCs from lymph nodes of tumor-bearing mice. Importantly, we demonstrate that TADCs are broadly conserved between mice and humans, although species-specific differences may exist in some subsets and states. Moreover, we present a comprehensive assessment of how different human TADC clusters associate with patient survival outcomes. Overall, we provide an in-depth characterization of the TADC compartment in mouse and human cancers, which can improve our understanding of the tumor microenvironment and contribute to the development of new anti-cancer therapies.

Indexed as

Dendritic CellsNeoplasmsAnimalsHumansLymph NodesMiceMice, Inbred C57BLSingle-Cell AnalysisSingle-Cell Gene Expression AnalysisTumor Microenvironment

Identifiers

PMID42218150
PMCPMC13392122

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.